Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Core Insights - Zacks Premium offers various tools to enhance stock market investment confidence and knowledge [1] - The Zacks Style Scores are designed to complement the Zacks Rank, providing additional stock ratings based on value, growth, and momentum [3][4][5][6][7] Zacks Style Scores - Each stock is rated from A to F based on value, growth, and momentum characteristics, with A being the highest score [4] - The Value Score identifies attractive and discounted stocks using ratios like P/E and Price/Sales [4] - The Growth Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings [5] - The Momentum Score helps investors capitalize on price trends, utilizing factors like price changes and earnings estimate revisions [6] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stock selection [7] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors, with 1 (Strong Buy) stocks averaging a +23.75% annual return since 1988, outperforming the S&P 500 [8] - There can be over 800 top-rated stocks available, making it essential to use Style Scores for effective selection [9] - To maximize returns, investors should target stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] Stock to Watch: Labcorp Holdings - Labcorp Holdings is a leading healthcare diagnostics company, known for its clinical laboratory services and drug development support [12] - Currently rated 3 (Hold) on the Zacks Rank, Labcorp has a VGM Score of A and a Momentum Style Score of A, with shares up 1.5% in the past four weeks [13] - Recent upward revisions in earnings estimates for fiscal 2025 have increased the Zacks Consensus Estimate by $0.22 to $16.27 per share, with an average earnings surprise of +2.5% [13][14]